H.R. 9703 — Improving Access to Transfusion Care for Hospice Patients Act of 2026

This section requires the Center for Medicare and Medicaid Innovation to establish and implement, within one year of enactment, a model testing separate Medicare payment for blood transfusions furnished to hospice patients at the amount that would otherwise apply under title XVIII. The CMI must evaluate the model by comparing participants to similar non-participants on chemotherapy services in the last 14 days of life, hospital utilization in the last 30 days of life, days receiving hospice care, transfusion rates and frequency, and other metrics.